Key Drivers
- Margin Expansion
- Strong Liquidity
- Interest Coverage
AIAI Summary
ICUI is shifting from a deleveraging turnaround to a proof-of-conversion story, offering upside if its recent margin and free-cash-flow gains persist and pump demand accelerates, but investors should wait for repeatable cash conversion and clarity on the >$500M Austin expansion before underwriting a durable rerating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Strong Liquidity
- •Interest Coverage
ICUI's improving margins, free cash flow, liquidity, and debt reduction are encouraging, but weak interest coverage, high intangibles, and elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Persistent lower lows
- •Oversold momentum
- •Breakout confirmation
ICUI is in a steep last-month downtrend toward $152–$153 support; despite extremely oversold conditions, wait for a break above $160–$161 to signal stabilization, while a drop below $152 would worsen the outlook.
Sharp 16.5% last-month decline indicates unusually strong selling pressure
Sentiment & News
Key News Insights:
- •Major stake purchases
- •CFO share sales
- •Conference outreach
ICU Medical saw strong institutional accumulation and investor outreach, partially offset by modest CFO share sales, signaling broadly positive market interest.
Institutional buying could support sentiment and the stock's near-term outlook despite insider selling
Similar Companies in Healthcare
Other companies in the same sector with AI ratings